Some aspects of pharmacoeconomic analysis results interpretation

Some aspects of pharmacoeconomic analysis results interpretation

Saved in:

Bibliographic Details
Main Author:	Sh F Erde
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2004-08-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/949
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Russian registry of patients receiving rituximab: results of pharmacoeconomic analysis
by: V N Amirdjanova, et al.
Published: (2009-02-01)

Pharmacoeconomic aspects of COVID-19 treatment
by: I. V. Rogova, et al.
Published: (2021-10-01)

Pharmacoeconomic aspects of osteoporosis problem: analysis of patients willing to pay for the treatment
by: Y F Lesnyak, et al.
Published: (2005-02-01)

Epidemiological and pharmacoeconomic aspects of HIV infection in military
by: Yu. I. Bulankov, et al.
Published: (2021-03-01)

Pharmacoeconomic aspects of the treatment of diabetic foot syndrome
by: Marina Fedorovna Kalashnikova, et al.
Published: (2010-06-01)

PHARMACOECONOMIC ASPECTS OF EPLERENONE USAGE IN CHRONIC HEART FAILURE
by: Yu. M. Lopatin, et al.
Published: (2015-08-01)

Pharmacoeconomic aspects of the therapy for moderate and severe psoriatic arthritis
by: A. V. Rudakova, et al.
Published: (2021-07-01)

Pharmacoeconomic aspects of vaccination against Pneumococcal Infection in Russia
by: A. V. Rudakova, et al.
Published: (2014-09-01)

Pharmacoeconomic aspects of recurrent / refractory chronic lymphocytic leukemia treatment
by: A. V. Rudakova, et al.
Published: (2020-04-01)

PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY
by: A. V. Rudakova, et al.
Published: (2017-08-01)

Pharmacoeconomic analysis of the use of tocilizumab in therapy for rheumatoid arthritis:imitation simulation
by: Dmitry Vladimirovich Goryachev, et al.
Published: (2010-04-01)

VACCINATION AGAINST PNEUMOCOCCAL INFECTIONS IN RUSSIAN FEDERATION: SOCIAL AND PHARMACOECONOMIC ASPECTS
by: A. V. Rudakova, et al.
Published: (2018-10-01)

Vaccination against Pneumococcal Infections of High-Risk People: Pharmacoeconomic Aspects
by: A. V. Rudakova, et al.
Published: (2020-01-01)

Quality of life of patients with low back pain and pharmacoeconomic aspects of the treatment
by: T V Chernyshova, et al.
Published: (2005-04-01)

Research of marketing and pharmacoeconomic aspects of the domestic market of preparations used for biorevitalization
by: N. O. Tkachenko, et al.
Published: (2021-03-01)

Pharmacoeconomic aspects of the use of sulfonylurea drugs in type 2 diabetes mellitus
by: Alla Vsevolodovna Rudakova
Published: (2011-09-01)

PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
by: A. V. Rudakova
Published: (2015-09-01)

Pharmacoeconomic analysis of antiretroviral therapy regimes in the Syrian Arab Republic
by: Yu. Sh. Gushchina, et al.
Published: (2023-07-01)

PHARMACOECONOMIC ANALYSIS OF EFFICACY OF DIFFERENT MODES OF ANTIBIOTIC PROPHYLAXIS IN CHOLECYSTECTOMY
by: A. N. Poborskiy, et al.
Published: (2016-10-01)

Pharmacoeconomic analysis in various nosologies
by: A. A. Svistunov, et al.
Published: (2016-06-01)

PHARMACOECONOMIC EFFECTIVENESS OF SOME MODERN METHODS OF THERAPY IN CYSTIC FIBROSIS CHILDREN
by: N.Yu. Kashirskaya, et al.
Published: (2006-06-01)

PHARMACOECONOMIC ASPECT OF OMALIZUMAB APPLICATION AMONG THE PATIENTS, SUFFERING FROM THE BRONCHIAL ASTHMA
by: A.S. Kolbin, et al.
Published: (2008-07-01)

PHARMACOECONOMIC ASPECTS OF NICOTINE ADDICTION TREATMENT IN PATIENTS WITH ANGINA REQUIRING CARDIAC SURGERY
by: A. V. Rudakova, et al.
Published: (2015-12-01)

PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT
by: A. V. Rudakova
Published: (2015-09-01)

Marketing research and pharmacoeconomic aspects of medicinal cosmetic products containing azelaic acid
by: O. Р. Kilieieva
Published: (2019-03-01)

Pharmacoeconomic aspects of oral vinorelbine application: a budget impact analysis considering the new registered price
by: D. A. Ivanov, et al.
Published: (2021-07-01)

THE FEATURES OF METHODOLOGY FOR PHARMACOECONOMICS ANALYSIS OF VACCINATION
by: A. Yu. Kulikov, et al.
Published: (2015-03-01)

Pharmacoeconomic aspects of the targeted drugs use in psoriatic arthritis in context of the Russian healthcare system
by: O. I. Ivakhnenko, et al.
Published: (2022-10-01)

COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS
by: M. B. Kubaeva, et al.
Published: (2017-08-01)

Pharmacoeconomics of HIV-infection
by: R. I. Yagudina, et al.
Published: (2018-02-01)

PRELIMINARY RESULTS OF COMPARATIVE PHARMACOECONOMIC PROSPECTIVE STUDY OF DIFFERENT THERAPIES OF ARTERIAL HYPERTENSION
by: E. I. Tarlovskaya, et al.
Published: (2015-12-01)

Pharmacoeconomics of Antibiotic Therapy
by: Jacques Le Lorier
Published: (1994-01-01)

Some considerations about the assessment of evaluative instruments and the interpretation of their results.
by: Luis Alberto Corona Martínez
Published: (2003-07-01)

PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC ANALYSIS OF TREATMENT OF ENDOMETRIT IN-HOSPITAL
by: L. Yu. Chernikova, et al.
Published: (2015-12-01)

PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE
by: E. I. Tarlovskaya, et al.
Published: (2015-09-01)

Pharmacoeconomics of spastic cerebral palsy
by: R. I. Yagudina, et al.
Published: (2018-02-01)

SEARCH OF INFORMATION IN PHARMACOECONOMIC RESEARCH
by: R. I. Yagudina, et al.
Published: (2015-03-01)

Pharmacoeconomics of chronic kidney disease
by: R. I. Yagudina, et al.
Published: (2018-02-01)

Review of open libraries for pharmacoeconomic analysis in R environment
by: I. A. Lackman, et al.
Published: (2024-11-01)

Pharmacoeconomic analysis of fluid therapy in the treatment of patients with peritonitis
by: R. I. Yagudina, et al.
Published: (2015-03-01)